Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

作者：Martin Markowitz, Ian Frank, Robert M. Grant, Kenneth H. Mayer, Richard Elion, Deborah Goldstein, Chester Fisher, Magdalena E. Sobieszczyk, Joel E. Gallant, Hong‐Van Tieu, Winkler G. Weinberg, David A. Margolis, Krischan J Hudson, Britt Stancil, Susan L. Ford, Parul Patel, Elizabeth Gould, Alex R. Rinehart, Kimberly Y. Smith, William Spreen · 发表于：The Lancet HIV · 年份：2017 · DOI：10.1016/s2352-3018(17)30068-1 · 被引用次数：222 · 研究领域：HIV/AIDS drug development and treatment、HIV-related health complications and treatments、HIV Research and Treatment